Cited by 458Neurological Disease Mechanisms and TreatmentsNeuroscience and Neuropharmacology ResearchAdvanced Glycation End Products research

Ageing and diabetes: implications for brain function

Biessels, Geert Jan, van der Heide, Lars P, Kamal, Amer, Bleys, Ronald L.A.W, Gispen, Willem Hendrik·2002·European Journal of Pharmacology

Abstract

Diabetes mellitus is associated with moderate cognitive deficits and neurophysiological and structural changes in the brain, a condition that may be referred to as diabetic encephalopathy. Diabetes increases the risk of dementia, particularly in the elderly. The emerging view is that the diabetic brain features many symptoms that are best described as "accelerated brain ageing." The clinical characteristics of diabetic encephalopathy are discussed, as well as behavioural (e.g. spatial learning) and neurophysiological (e.g. hippocampal synaptic plasticity) findings in animal models. Animal models can make a substantial contribution to our understanding of the pathogenesis, which shares many features with the mechanisms underlying brain ageing. By unravelling the pathogenesis, targets for pharmacotherapy can be identified. This may allow treatment or prevention of this diabetic complication in the future. We discuss changes in glutamate receptor subtypes, in second-messenger systems and in protein kinases that may account for the alterations in synaptic plasticity. In addition, the possible role of cerebrovascular changes, oxidative stress, nonenzymatic protein glycation, insulin and alterations in neuronal calcium homeostasis are addressed.

Integrity signals

Registry

Crossref · 10.1016/s0014-2999(02)01486-3

Cites

186 of 186 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • It is possible that IGT leads to elevations in glucose levels sufficient to worsen the effects of other subtle brain insults by perhaps increasing excitotoxic free radical-induced damage.

    “Although our subjects were not diabetic, it is also possible that the IGT leads to elevations in glucose levels sufficient to worsen the effects of other subtle brain insults by perhaps increasing excitotoxic free radical-induced damage (for a review, see ref. 36).”
  • Only one of the review articles that summarised the available data on the relationship between diabetes and cognitive dysfunction provided a quantitative estimate.

    “Indeed, only one [7] of the review articles that summarised the available data pertaining to this relationship [4, 6 -11] provided a quantitative estimate.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Biessels, G. J., van der Heide, L. P., Kamal, A., Bleys, R. L. A. W., & Gispen, W. H.
Affiliations
University Medical Center Utrecht (NL)
Corresponding author
Biessels, Geert Jan
Venue
European Journal of Pharmacology
Publisher
Elsevier BV
Published
2002-04
Volume
441
Issue
1-2
Pages
1-14
ISSN
0014-2999 (ISSN-L)
OpenAlex
W2141567007
Cited by
458
References
186
Citations by year
2026: 2 · 2025: 7 · 2024: 5 · 2023: 11 · 2022: 14 · 2021: 21 · 2020: 22 · 2019: 19 · 2018: 14 · 2017: 18 · 2016: 22 · 2015: 25 · 2014: 34 · 2013: 26 · 2012: 30
FWCI
2.38
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
Keywords
diabetes mellitus, brain aging, diabetic encephalopathy, dementia, cognitive impairment, hippocampal synaptic plasticity, spatial learning, glutamate receptor subtypes, second messenger signaling, protein kinases, cerebrovascular changes, oxidative stress, insulin, neuronal calcium homeostasis, animal models of diabetes
MeSH terms
Aging, Animals, Brain, Calcium, Cognition, Diabetes Mellitus, Humans, Neuronal Plasticity, Peripheral Nervous System Diseases, Synapses, Oxidative Stress

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review